title: [Cerebritis and cerebral abscess due to Streptococcus pneumoniae in a newborn].
authors: José María
authors: JM
authors: Lloreda-García
authors: Carmen
authors: C
authors: Martinez-Ferrandez
authors: Salvador
authors: S
authors: Gil-Sánchez
authors: Joaquín
authors: J
authors: Susmozas-Sánchez
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D016470:Bacteremia / Q000150:complications / Q000382:microbiology; D001922:Brain Abscess / Q000382:microbiology*; D001988:Bronchiolitis / Q000150:complications; D002316:Cardiotonic Agents / Q000627:therapeutic use; D002543:Cerebral Hemorrhage / Q000209:etiology; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D006801:Humans; D016867:Immunocompromised Host; D007231:Infant, Newborn; D008279:Magnetic Resonance Imaging; D008297:Male; D008586:Meningitis, Pneumococcal / Q000134:cerebrospinal fluid / Q000175:diagnosis* / Q000188:drug therapy; D011008:Pneumococcal Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D018357:Respiratory Syncytial Virus Infections / Q000150:complications; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D013154:Spleen / Q000002:abnormalities; D013296:Streptococcus pneumoniae / Q000302:isolation & purification; D014640:Vancomycin / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D002316:Cardiotonic Agents; D014640:Vancomycin; D012293:Rifampin